Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to Luna Innovations

Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines.

Related Posts

Comments are closed.